Did you know? According to a report published by the WHO, adherence rates in developed countries average only about 50%, and there is little data about adherence in countries where access to care is more limited or consistent. Adherence is a key factor associated with the effectiveness of all pharmacological therapies but is particularly critical for medications prescribed for chronic conditions. Of all medication-related hospitalizations that occur in the United States, between one-third and two-thirds are the result of poor medication adherence. Inadequate adherence also is a major player in adverse events to medications.
Welcome to this episode of Physician’s Weekly Podcast. My name is Dr Rachel Giles, from Medicom Medical Publishers, in collaboration with Physician’s Weekly. We have 3 fantastic in-depth interviews for you this week, touching on improved hospital workflow for stroke patients, a presentation on management of gout in dialysis patients, and medication experience.
In this 31st episode of the Physician’s Weekly Podcast, we speak with Dr Danny Sands, about addressing barriers such as understanding their condition, cultural issues, and denial can help patients avoid adverse effects from poor medication adherence. Dr Sands is a primary care physician at Beth Israel Deaconess Medical Center, and is a founder and co-chair of the board of the Society for Participatory Medicine. In 2009 he was recognized by HealthLeaders Magazine as one of “20 People Who Make Healthcare Better.”
Also in this episode, we speak with Dr Anthony Bleyer, Professor of nephrology at the Wake Forest School of Medicine, North Carolina, about his presentation of the results of a cohort study into the prevalence, risk factors and outcomes of gout in dialysis patients at the Kidney Week of the American Society of Nephrology, which was held virtually 4-7 November, 2021 .
But first, Physician’s Weekly speaks with Ferdinand Hui, about workflow optimization and mobile technology. Dr. Hui hails from Johns Hopkins – but is currently working in Hawaii- and we talk about the deluge of communication apps in hospitals and what makes something valuable, versus noise. He recently published a paper in Journal of Neurointerventional Surgery  on the impact of mobile apps on treatment times for patients with stroke where time is of the essence. His team showed that that utilization of RapidAI mobile application can significantly reduce treatment times in stroke care by accelerating the process of mobilizing stroke clinicians and interventionalists.
1. Bleyer AJ, et al. Risk Factors and Outcomes of Gout in Dialysis Patients: A Cohort Study of the United States Renal Data System (USRDS). PO0792, American Society of Nephrology: Kidney Week 2021, 04-07 November.
2. Murray NM, Unberath M, Hager GD, Hui FK. Artificial intelligence to diagnose ischemic stroke and identify large vessel occlusions: a systematic review. J Neurointerv Surg. 2020 Feb;12(2):156-164.